Finance
GSK Boosts 2024 Profit Outlook, Anticipates H1 Sales Surge
GSK, a UK-based pharmaceutical giant, has updated its financial outlook, projecting higher profits and sales for the upcoming year. The company now forecasts an 8% to 10% increase in annual adjusted earnings per share, marking an improvement from its previously estimated growth range of 6% to 9%. This optimistic revision